IP Library Granted Patent US 8,088,576
Granted Patent B2
US 8,088,576 · App. 11/587,581 · Granted Jan 3, 2012

Method and assembly for DNA isolation with dry reagents

Assignee: Siemens Aktiengesellschaft
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,088,576
App. No.
11/587,581
Granted
Jan 3, 2012
Kind
B2
Abstract

A DNA isolation method by removal of constituents, interfering with a subsequent PCR is disclosed. According to an embodiment of the method, all substances and method steps are fully integrated into a closed unit (cartridge) for single use, which allows entry of a DNA-containing sample and DNA-binding substrates are used for isolating the released DNA. In particular, when the method is applied to DNA isolation from whole blood by disruption of white blood cells, the reagents, required for carrying out the cell disruption and other reactions, are stored in a form which is stable at room temperature. For disrupting the white blood cells and for DNA isolation, a dry stored lysis reagent is dissolved in an aqueous solution and brought into contact with the white blood cells. The corresponding assembly includes a unit, for housing DNA-containing biological containers and/or reagents, whereby at least one microchannel is provided to contain reagents, whereby the reagent is present in the microchannel as a dry mixture with a negligible vapor pressure, which forms a stable substance at room temperature.

Claims (19)

1. A method for DNA isolation while removing constituents that interfere with a subsequent PCR, the method comprising:

integrating materials in a closed analysis single-use unit which allows a sample with DNA to enter;

releasing the DNA by using dry reagents stored in the unit in a form that is stable at room temperature;

isolating the released DNA using DNA-binding substrates, wherein the DNA-binding substrates are magnetic beads;

bringing a dry matrix, lying on a wall in a disintegration channel of the unit and including lysis reagents and the DNA-binding substrates, in contact with biological structures to disintegrate the biological structures containing the DNA, the magnetic beads being distributed in the dry matrix such that the DNAs released by contact with the lysis reagents are bound directly and simultaneously to the DNA-binding substrates; and

collecting the substrates with the bound DNAs and transporting the collected substrates to a site of the PCR.

2. The method as claimed in claim 1 , wherein white blood cells are used as the biological structures containing DNA.

3. The method as claimed in claim 2 , wherein the lysis reagents are brought in contact with the white blood cells with the aid of water, the lysis reagents being stored dry and storage-stable.

4. The method as claimed in claim 1 , further comprising diluting the sample with DNA, dissolving or suspending the dry reagents, disintegrating the biological structures and binding the DNA released by contact with the lysis reagents in a single step, after the sample with DNA is in the unit.

5. The method as claimed in claim 1 , wherein the released DNA is bound and transported by the magnetic beads to at least one of a collection site and a reaction site.

6. The method as claimed in claim 1 , wherein the magnetic beads are concentrated by applying a magnetic field.

7. The method as claimed in claim 6 , wherein flowing magnetic beads are concentrated by a static magnetic field.

8. The method as claimed in claim 1 , wherein the PCR is carried out by thermocycling with dryly-stored, water-soluble reagents at a reaction site.

9. The method as claimed in claim 1 , wherein the sample with DNA is a blood sample put into the unit diluted and pumped through a reagent channel to a reaction channel for the PCR.

10. The method as claimed in claim 9 , wherein residual blood, blood constituents and the reagent waste remain in the unit after the DNA isolation, so that a user cannot directly contact the residual blood, the blood constituents and the reagent waste.

11. The method as claimed in claim 1 , wherein a disposable product is used as the single-use unit in which the PCR is performed.

12. The method as claimed in claim 11 , wherein the disposable product is a cartridge.

13. The method as claimed in claim 12 , wherein the cartridge is made of plastic.

14. The method as claimed in claim 1 , wherein the dry matrix, having the magnetic beads therein, is adhered to the wall by adding a film-forming agent to the dry matrix.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 25, 2006
From: GUMBRECHT, WALTER; PAULICKA, PETER; STANZEL, MANFRED
To: SIEMENS AKTIENGESELLSCHAFT
Reel/Frame 018475/0638 →
Priority Claims (1)
DE 10 2004 021 780 · Apr 30, 2004 · national
Continuity (1)
Related Publication 20070219366A1 · Sep 20, 2007